4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-017564
Chief Development Officer sold 3,009 shares at $6.87 ($20,672)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaiser Peter · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Sale : show line 1 in the form 10b5-1 | −3,009 | $6.87 | $20,672 | 210,078 | D |
| Open-market sales · 3,009 sh · avg $6.87 · $20,672 | ||||||
Loading xslF345X05/tm257640-2_4seq1.xml…